skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Is there a case to be made for trading HCG with it sitting at current levels? I realize that your service advocates careful and balanced portfolio management but there do seem to be opportunities to harvest $.40/.50 cent swings.

As a second part to the question, do you see the company going to Zero or has it already bottomed out as CXR and VRX did before it with the short attacks. The underlying business seems better than it is getting credit for but perhaps that doesn't matter.
Read Answer Asked by Tim on May 08, 2017
Q: Hi 5i,

What are the forward EPS and revenues for Aphria (APH)? What is there trailing and forward quarterly growth rate for revenues at? Also what is there cash and debt position?
What is the cost of production metric that is used in the industry and how do they compare?

Thank you,

Shane
Read Answer Asked by SHANE on May 08, 2017
Q: I see on Friday a US Law Firm announced its investigating whether the offer for Span-America was "fair" for Span shareholders. I find this confusing. Isn't this usually instigated by an Investment Bank or large shareholder? What can be unfair about an offer to buy shares? If you don't want to sell, then don't tender. Do you see this causing the offer to rise? Could there be anything illegal about this offer?
Read Answer Asked by Barry on May 08, 2017
Q: Just wanted to make a correction to a reply you gave to a previous question on EFN. You mentioned that the small company facing the lawsuit is Clarion. As you can see from the extract below, it's actually Celadon Group Inc.

Keep up the great work.

----------------------------------------------------------

NEW YORK, April 24, 2017 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Celadon Group Inc. (NYSE:CGI) who purchased shares between December 30, 2016 and April 18, 2017. The action, which was filed in the U.S. District Court for the Southern District of New York, alleges that the Company violated federal securities laws.

In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (i) CGI's equity contribution to its joint venture with Element Financial Corp. was $68.2 million, rather than the $100 million contribution the Company reported in its public filings; (ii) the Company is being actively investigated by the SEC; and (iii) that as a result of the foregoing, CGI's publicly disseminated financial statements were materially false and misleading.

Shareholders have until June 19, 2017 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
Read Answer Asked by karl on May 08, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!